AbbVie Aktie

175,72USD -0,82USD -0,46%
AbbVie für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A1J84E / ISIN: US00287Y1091
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,92
Vanguard Group, Inc. (Subfiler) 9,25
The Vanguard Group, Inc. 9,08
State Street Corp. 4,48
Vanguard Total Stock Market ETF 3,16
BlackRock Fund Advisors 2,87
Vanguard 500 Index Fund 2,65
BlackRock Institutional Trust Co. NA 2,18
Capital Research & Management Co. (International Investors) 2,08
Geode Capital Management LLC 2,05
Capital Research & Management Co. (Global Investors) 1,88
JPMorgan Investment Management, Inc. 1,84
Charles Schwab Investment Management, Inc. 1,35
Norges Bank (13F) 1,27
Morgan Stanley Smith Barney LLC 1,24

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 30 000 47 000 50 000 50 000 50 000
Umsatz pro Mitarbeiter in Mio. EUR 1,11 0,97 1,12 1,16 1,09

Bilanz (in Mio. USD) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 49 519 24 173 27 928 28 463 33 002
Summe Anlagevermögen 39 596 126 392 118 601 110 342 101 709
Summe Aktiva 89 115 150 565 146 529 138 805 134 711

Bilanz (in Mio. USD) - Passiva

2019 2020 2021 2022 2023
Summe Fremdkapital 97 287 137 468 131 093 121 518 124 314
Summe Eigenkapital -8 172 13 097 15 436 17 287 10 397
Summe Passiva 89 115 150 565 146 529 138 805 134 711

Adresse

1 North Waukegan Road, 60064-6400 North Chicago
Telefon +1 (847) 932-7900
Internet http://www.abbvie.com

Management

Azita Saleki-Gerhardt
Co-Chief Operations Officer & Executive VP
Brett J. Hart
Independent Director
Brian L. Durkin
Vice President
Carrie Strom
Senior VP & President-Global Allergan Aesthetics
Edward J. Rapp
Independent Director
Esteban Plata
Vice President-Western Europe & Canada
Frederick H. Waddell
Independent Director
Glenn Fletcher Tilton
Independent Director
Jennifer L. Davis
Independent Director
Kevin K. Buckbee
Senior Vice President & Controller
Liz Shea
Head-Investor Relations
Melody B. Meyer
Independent Non-Executive Director
Nicholas Donoghoe
Chief Business & Strategy Officer
Perry C. Siatis
Secretary, Executive VP & General Counsel
Rebecca Brown Roberts
Independent Director
Richard A. Gonzalez
Executive Chairman
Robert A. Michael
Chief Executive Officer & Director
Robert J. Alpern
Independent Director
Roopal Thakkar
Chief Scientific Officer, Executive VP-R&D
Roxanne Schuh Austin
Lead Independent Director
Scott T. Reents
Chief Financial Officer & Executive Vice President
Susan E. Quaggin
Independent Director
Thomas C. Freyman
Independent Director
Timothy J. Richmond
Chief Human Resources Officer & Executive VP
Todd D. Bosse
Vice President-Investor Relations
William H. L. Burnside
Independent Director